QQ客服 官方微博 反馈留言

	Therapeutic targets of hypercholesterolemia: HMGCR and LDLR
	Ma, Shizhan; Sun, Wenxiu; Gao, Ling; Liu, Shudong
刊名	DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY
	2019
卷号	12页码:1543-1553
关键词	cholesterol homeostasis CVD HMGCR LDLR
DOI	10.2147/DMSO.S219013
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4549381
专题	山东大学
作者单位	1.Shandong First Med Univ, Shandong Prov Hosp, Dept Endocrinol & Metab, Jinan 250021, Shandong, Peoples R China. 2.[Ma, Shizha
推荐引用方式 GB/T 7714	Ma, Shizhan,Sun, Wenxiu,Gao, Ling,et al. Therapeutic targets of hypercholesterolemia: HMGCR and LDLR[J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY,2019,12:1543-1553.
APA	Ma, Shizhan,Sun, Wenxiu,Gao, Ling,&Liu, Shudong.(2019).Therapeutic targets of hypercholesterolemia: HMGCR and LDLR.DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY,12,1543-1553.
MLA	Ma, Shizhan,et al."Therapeutic targets of hypercholesterolemia: HMGCR and LDLR".DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY 12(2019):1543-1553.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。